Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 87
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.01-085 - A Multicenter Phase 1B Study of Ceritinib plus Nivolumab in Patients with ALK+ NSCLC
09:30 - 09:30 | Author(s): A. Shaw
- Abstract
Loading...
-
+
MINI 01 - Pathology
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 14
- Moderators:W.A. Franklin
- Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 2c-3c
-
+
MINI01.11 - Transcriptome Sequencing of Tumor vs. Surrounding Non-Malignant Lung Tissue in Non-Small Cell Lung Cancer
11:45 - 11:50 | Author(s): K. Reynders
- Abstract
Loading...
-
+
MS 04 - Harnessing the Full Potential of the Immune System
- Type: Mini Symposium
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 5
- Moderators:C. Butts
- Coordinates: 9/07/2015, 14:15 - 15:45, Four Seasons Ballroom F3+F4
-
+
MS04.03 - Vaccines
15:00 - 15:20 | Author(s): J. Vansteenkiste
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 18 - Non PD1 Immunotherapy and Angiogenesis
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 7
- Moderators:C. Butts
- Coordinates: 9/08/2015, 10:45 - 12:15, Four Seasons Ballroom F1+F2
-
+
ORAL18.03 - Discussant for ORAL18.01, ORAL18.02
11:07 - 11:17 | Author(s): J. Vansteenkiste
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 20 - Chemoradiotherapy
- Type: Oral Session
- Track: Treatment of Locoregional Disease – NSCLC
- Presentations: 7
- Moderators:G. Blumenschein
- Coordinates: 9/08/2015, 10:45 - 12:15, 201+203
-
+
ORAL20.02 - Safety Results of the Consolidation Phase of a Phase III (PROCLAIM): Pemetrexed, Cisplatin or Etoposide, Cisplatin plus Thoracic Radiation Therapy followed by Consolidation Cytotoxic Chemotherapy in Locally Advanced Nonsquamous Non-Small Cell Lung Cancer
10:56 - 11:07 | Author(s): R. Govindan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MS 19 - Global Nursing Issues in Lung Cancer
- Type: Mini Symposium
- Track: Nursing and Allied Professionals
- Presentations: 7
- Moderators:P. Hollen
- Coordinates: 9/08/2015, 14:15 - 15:45, 708+710+712
-
+
MS19.01 - Nursing Challenges in Clinical Trials
14:20 - 14:33 | Author(s): C. Oyen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 22 - New Technology
- Type: Mini Oral
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 13
- Moderators:L. Byers
- Coordinates: 9/08/2015, 16:45 - 18:15, 205+207
-
+
MINI22.06 - The Challenge of Molecular Testing for Clinical Trials in Advanced Non-Small Cell Lung Cancer Patients: Analysis of a Prospective Database
17:15 - 17:20 | Author(s): S. Lepers
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 91
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.01-078 - Avelumab (MSB0010718C), an Anti-PD-L1 Antibody, Evaluated in a Phase III Trial versus Docetaxel in Patients with Relapsing NSCLC
09:30 - 09:30 | Author(s): K. Park
- Abstract
Loading...
-
+
P3.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 134
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.04-009 - Evaluation of RT-PCR Methodology for ALK Assessment in Patients with NSCLC in Europe: Results from the ETOP Lungscape Project
09:30 - 09:30 | Author(s): I. Letovanec
- Abstract
Loading... -
+
P3.04-053 - SPECTAlung: Screening Patients with Thoracic Tumors for Efficient Clinical Trial Access
09:30 - 09:30 | Author(s): B. Besse
- Abstract
Loading...
-
+
ORAL 34 - Quality/Survival/Prognosis in Localized Lung Cancer
- Type: Oral Session
- Track: Treatment of Localized Disease - NSCLC
- Presentations: 8
- Moderators:B.C. Cho
- Coordinates: 9/09/2015, 16:45 - 18:15, 201+203
-
+
ORAL34.03 - Prognostic Factors in Early Stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
17:07 - 17:18 | Author(s): B.C. Cho
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
